Northwest Biotherapeutics | NWBO - Current Assets


Northwest Biotherapeutics reported $7.2M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Agenus USD 133.95M 120.61M Sep/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Celldex Therapeutics USD 604.34M 44.06M Sep/2025
Eisai JPY 840.88B 50.18B Dec/2025
Infinity Pharmaceuticals USD 19.91M 8.46M Jun/2023
Merck USD 47.56B 10.49B Sep/2025
Northwest Biotherapeutics USD 7.2M 1.04M Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Plus Therapeutics USD 9.83M 1.75M Dec/2023
Roche Holding CHF 38.73B 3.03B Dec/2025